Akheel Mohammad, Senthilmurugan M, Jain Amit, Chahwala Qutubuddin, Sherlin Herald J, Wadhwania Ashmi
Oral & Maxillofacial Surgery, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu India.
Dept of Oral Oncology, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu India.
J Maxillofac Oral Surg. 2022 Dec;21(4):1065-1073. doi: 10.1007/s12663-022-01797-0. Epub 2022 Sep 29.
Oral squamous cell carcinomas (OSCC) are the most common type of variant causing oral cancers, contributing for around 90%. The overall survival of these patients is below 50%. The postoperative overall survival (OS) has not improved over years much despite of advanced surgical techniques and invention of various anticancer drugs. There was always a requirement for a non-invasive molecular marker to predict the prognosis of these patients. The epidermal growth factor and their receptors are not only thought to play a critical but also an influential role in growth of the cell and differentiation in normal/ healthy tissues. They also play an important role in malignant progression of disease and tumorigenesis. A better and sound understanding of mechanisms at molecular level and identification of potential oncogenes in OSCC may provide innovative therapeutic decisions such as targeted therapy in management of these cancer patients.
AIM & OBJECTIVES: The aim of this study is to check whether epidermal growth factor expression is a prognosticator in oral squamous cell carcinoma and also to propose a mathematical model to find the prognosis of the patients which have not been done so far in the literature.
MATERIALS & METHODS: The study was a prospective cohort study with 25 patients who had biopsy proven OSCC who reported to our hospital from July 2017 to June 2019. The data collected from their histopathological report for this prospective study and model were: surgical margins (superior, inferior, anterior and posterior), depth of tumor, lymph nodal metastasis, lymphovascular invasion and scoring of epidermal growth factor receptor (EGFR) expression done by immunohistochemistry (IHC) on wax blocks.
EGFR expression on surgical margins was found to have a -value of 0.023 which was significant statistically. EGFR expression showed a statistically significant value 0.002 as independent marker in prognosis with sensitivity of 97.7% and specificity of 61.2%. The tumor depth of infiltration showed an insignificant correlation with pathological Tumor, Node, Metastasis (TNM) staging with a p value of 0.860. A mathematical model linear regression equation was proposed which predicted a cutoff value above 16, the prognosis of the patient being bad (Stages III and IV), and below 16, the prognosis of the patient being good (Stages I and II).
This study put forward a proposed mathematical model by incorporating all important parameters to predict the prognosis of the patients. EGFR expression is one such important parameter to be considered to develop anti-EGFR agents to improve the OS of the patients.
The online version contains supplementary material available at 10.1007/s12663-022-01797-0.
口腔鳞状细胞癌(OSCC)是导致口腔癌的最常见变异类型,约占90%。这些患者的总体生存率低于50%。尽管有先进的手术技术和各种抗癌药物的发明,但多年来术后总体生存率(OS)并未有太大改善。一直需要一种非侵入性分子标志物来预测这些患者的预后。表皮生长因子及其受体不仅被认为在细胞生长和正常/健康组织的分化中起关键作用,而且起有影响的作用。它们在疾病的恶性进展和肿瘤发生中也起重要作用。更好地从分子水平理解机制并鉴定OSCC中的潜在癌基因,可能为这些癌症患者的管理提供创新的治疗决策,如靶向治疗。
本研究的目的是检查表皮生长因子表达是否为口腔鳞状细胞癌的预后指标,并提出一个数学模型以找出患者的预后情况,这在文献中尚未有过。
该研究是一项前瞻性队列研究,纳入了2017年7月至2019年6月期间到我院就诊、经活检证实为OSCC的25例患者。从他们的组织病理学报告中收集用于该前瞻性研究和模型的数据包括:手术切缘(上、下、前、后)、肿瘤深度、淋巴结转移、淋巴管侵犯以及通过对蜡块进行免疫组织化学(IHC)检测的表皮生长因子受体(EGFR)表达评分。
发现手术切缘上的EGFR表达的P值为0.023,具有统计学意义。EGFR表达作为独立预后指标显示出统计学显著的P值0.002,敏感性为97.7%,特异性为61.2%。肿瘤浸润深度与病理肿瘤、淋巴结、转移(TNM)分期的相关性不显著,P值为0.860。提出了一个数学模型线性回归方程,该方程预测截断值高于16时患者预后不良(III期和IV期),低于16时患者预后良好(I期和II期)。
本研究通过纳入所有重要参数提出了一个预测患者预后的数学模型。EGFR表达是开发抗EGFR药物以改善患者OS时应考虑的一个重要参数。
在线版本包含可在10.1007/s12663 - 022 - 01797 - 0获取的补充材料。